PRESS JOSEPH received a stock award from RAPHAEL PHARMACEUTICAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/13/2023ACC: 0001213900-23-019556
+385K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
385K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+280K
Price / share
—
Trade value
—
% of position
New position
7/26/2022
0.00→280K
Total
Net shares
+280K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/26/2022 | A · Award | +280K | — | — | New position | 0.00 | 280K |
| Total | +280K | $0.00 | ||||||
Derivative Transactions1
Warrants to Purchase Common Stock
Direct
Converts to
Common Stock
105K shares
Shares
+105K
Strike price
1.12
Held after
105K
Exercisable
—
12/5/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants to Purchase Common Stock Direct | Common Stock105K shares | 12/5/2022 | A · Award | +105K | 1.12 | — | 105K |